Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Novocal
- Development stage
- Unknown
- Lead developer
- Captab Biotec
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Novocal is a brand line of calcium, vitamin D3, and multi-mineral/vitamin dietary supplements developed and marketed by Captab Biotec. The product line includes several formulations such as Novocal Tablets/Suspension, Novocal-Strong, Novocal-Fem, Novocal-D3, Novocal-Forte, and Novocal-Gold. These formulations are designed to support bone health, treat or prevent calcium and vitamin D deficiencies, and manage conditions like osteoporosis, hypocalcemia, and osteomalacia. The active ingredients across the product line typically include calcium (as calcium carbonate or coral calcium), vitamin D3 (as cholecalciferol or calcitriol), and supporting nutrients such as zinc, magnesium, vitamin K2-7, methylcobalamin, and L-methylfolate, which collectively enhance calcium absorption, promote bone mineralization, and support overall metabolic and skeletal health.
- Brand names
- NovocalNovocal SuspensionNovocal TabletsNovocal-D3Novocal-D-3Novocal-D 3Novocal-FemNovocal-ForteNovocal-GoldNovocal-Strong
- Other names
- calcium + vitamin d3 + zinc
02
Targets
CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Novocal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novocal.